Phase II trial of cis-dichlorodiammineplatinum(II) in cancer of the bilharzial bladder.
D002945:Cisplatin / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D012075:Remission, Spontaneous; D012552:Schistosomiasis / Q000150:complications*; D001749:Urinary Bladder Neoplasms / Q000150:complications / Q000188:drug therapy*
D002945:Cisplatin